We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
255 21 0 ARDM
Emcee:  Marvin Frank Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
230>>VALENCIA, Calif., Dec. 22 /PRNewswire-FirstCall/ -- MannKind Corporationtuck-12/23/2004
229In addition to the DRDC contract, Aradigm has been granted an exclusive worldwidTadsamillionaire-12/14/2004
228I see this as a good thing."With these agreements, Aradigm now owns a proprTadsamillionaire-12/14/2004
227>>What will ardm invest in now?<< >>HAYWARD, Calif., Dec. 13 tuck-12/13/2004
226--Aradigm Corporation (NASDAQ: ARDM) announced today that Dr. Bryan Lawlis, PresTadsamillionaire-12/2/2004
225Aradigm Announces Results From Clinical Study of Intraject Needle-Free System WiTadsamillionaire-12/1/2004
224>>VALENCIA, Calif., Nov. 10 /PRNewswire-FirstCall/ -- MannKind Corporationtuck-11/10/2004
223>>HAYWARD, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Aradigm Corporation (tuck-10/13/2004
222Wow. All sorts of strange and good news of late, strange developments. Fun.scaram(o)uche-9/28/2004
221What will ardm invest in now? rkrw-9/28/2004
220I would not have expected this. <i>Novo Nordisk Expands Licensing Righkeokalani'nui-9/28/2004
219[Inhaled morphine delivered using the AERx system in patients with moderate-to-stuck-9/17/2004
218MKND has a $475M market cap. CEO has a history of success with MiniMed, so perharkrw-9/6/2004
217>>MUNICH, Germany, Sept. 6 /PRNewswire-FirstCall/ -- MannKind Corporation tuck-9/6/2004
216Exubera does use excipients. I think that was one of the advantages aerx over exrkrw-8/26/2004
215No, though that struck me, too. I don't know why KOSP is targeting those patuck-8/26/2004
214KOSP program has been around a long time. Any idea why kosp is able to get such rkrw-8/26/2004
213Now KOSP is playing in the inhaled insulin space, too. Here's the relevant tuck-8/26/2004
212[Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison wituck-8/24/2004
211>>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 10, 2004--Alkermes, Inc. (Nasdaqtuck-8/10/2004
210Thanks to deeno for this ML report which mentions for the first time in the analtuck-6/10/2004
209It would appear that night time glucose levels, which derailed AERx, weren'ttuck-6/9/2004
208tuck, apparently7 exubera shared l/t safety and efficacy at ADA today. I didn&#keokalani'nui-6/7/2004
207INHL' studies continue to show no effect, but night time glucose levels not tuck-6/7/2004
206Nice, very nice, work. Might see if there is a footnote to that quote.keokalani'nui-5/26/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):